Meitheal Pharmaceuticals, Inc. is voluntarily recalling Vecuronium Bromide for Injection because the labeling lacks required warnings or Rx legend, the FDA said on Oct. 8, 2026.
How to tell if you have it
- Brand: Meitheal Pharmaceuticals
- Product: Vecuronium Bromide Injection
- NDC: 71288-744-11
- Lot# T1P0213A: Exp. 30-Apr-29
- Lot# T1P0313A: Exp. 30-Apr-29
- Lot# T1P0412A: Exp. 30-Sep-28
- Lot# T1P0413A: Exp. 30-Apr-29
- Lot# T1P0512A: Exp. 30-Sep-28
- Lot# T1P0513A: Exp. 30-Apr-29
The hazard
The hazard is that the labeling lacks a warning or Rx legend, according to the FDA.
Context
GovInfoNow's records show Meitheal Pharmaceuticals, Inc. has 3 other recalls on record since 2021-01-27. Other recent recalls of similar products include Meitheal Cetrorelix Acetate Injection Kit Recall (2026-02-09), Meitheal Glycopyrrolate Injection Recall (2021-09-03) and Meitheal Cisatracurium Injection Recall (2021-01-27). Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (2026-04-16), ValuHealth Acetaminophen Recall (2026-10-14) and Glenmark Recalls Abiraterone Acetate Tablets Due to Labeling Issue (2026-10-09).